Karen Harkness
$118,755.00asClinical Lead Heart Failure / CVCDM+5.69%
Employed by Cardiac Care Network of Ontario in 2016, according to Government of Ontario public salary records.
Salary Information
Historical salary and taxable benefits from 2015 to 2016.
Karen Harkness, Clinical Lead Heart Failure / CVCDM at Cardiac Care Network of Ontario, earned a disclosed salary of $118,755.00 in 2016 on the Ontario Sunshine List. This represents a 5.69% increase over the previous year's reported salary. Karen Harkness has appeared on the Ontario Sunshine List 2 times between 2015 and 2016, with reported earnings peaking at $118,755.00 in 2016. In addition to salary, $11,875.50 in taxable benefits was disclosed for 2016. Cardiac Care Network of Ontario reports under the Other Public Sector Employers sector of Ontario's public sector salary disclosure.
Top earning Clinical Lead Heart Failure / CVCDMs in Cardiac Care Network of Ontario
| Name | Salary |
|---|---|
| Karen Harkness | $118,755.00 |
Other employees at Cardiac Care Network of Ontario
| Name | Position | Salary |
|---|---|---|
| Cathy Cattaruzza Chief Operating Officer | Chief Operating Officer | $163,025.70 |
| Anne Forsey Director Clinical Services | Director Clinical Services | $145,257.58 |
| Gary Lee Director Decision Support | Director Decision Support | $127,003.50 |
| Michael Setterfield Program Director, Vascular Services | Program Director, Vascular Services | $122,999.24 |
| Jana Jeffrey Program Director, Clinical Operations and Services Delivery | Program Director, Clinical Operations and Services Delivery | $119,868.30 |
| Mark Cadeau Director Technology Services | Director Technology Services | $116,005.50 |
| Tracey Lynch Director Corporate Services | Director Corporate Services | $112,499.92 |
| Alan Wong Director Information Technology | Director Information Technology | $104,549.90 |
| Vevien Braga Senior Clinical Lead / QBPs | Senior Clinical Lead / QBPs | $103,993.50 |
| Garth Oakes Director Privacy and Research Development | Director Privacy and Research Development | $102,633.19 |